Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Lymphoma 7Leukemia 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Renal Cell 5Unspecified Adult Solid Tumor, Protocol Specific 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myeloid, Acute 4Burkitt Lymphoma 4Kidney Neoplasms 3Waldenstrom Macroglobulinemia 2Stomach Neoplasms 2Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Multiple Myeloma 2Melanoma 2Lymphoma, T-Cell, Cutaneous 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Blast Crisis 2Anemia, Refractory 2

Interventions

Cytarabine 85fludarabine phosphate 84Peripheral Blood Stem Cell Transplantation 75Cyclophosphamide 69Busulfan 62Mycophenolic Acid 50Cyclosporine 48Tacrolimus 47Etoposide 43Whole-Body Irradiation 41Antilymphocyte Serum 40Methotrexate 39Filgrastim 39Radiotherapy 29Melphalan 24Mitoxantrone 23Daunorubicin 23Idarubicin 21Cord Blood Stem Cell Transplantation 18Methylprednisolone 17Flow Cytometry 17sargramostim 15Granulocyte Colony-Stimulating Factor 15Clofarabine 15Transplantation 14Decitabine 14aldesleukin 12Gemtuzumab 12Thiotepa 11Bortezomib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Congenital Abnormalities × bryostatin 1 × Clear all
NCT00012376 2013-01-09

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Blast Crisis, Hemoglobinuria, Paroxysmal, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00017342 2010-03-01

Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia

Virginia Commonwealth University

Phase 2 Completed
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡